New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry
Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.
A federal appeals court in New York upheld his lifetime ban from the business.
More Stories
China accuses UK politicians of ‘arrogance’ in British Steel row
In the red: global wine sales fall to lowest levels since 1961
Nvidia expects to take $5.5bn hit as US tightens AI chip export rules to China